From: The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Variable | Normal liver histology (N = 94) | Non-NASH NAFLD (N = 143) | NASH (N = 104) | P-value* | P-value†| P-value‡ |
---|---|---|---|---|---|---|
Age (yrs) | 41.48 ± 10.86 | 44.08 ± 11.39 | 46.42 ± 10.94 | 0.0814 | 0.0017 | 0.1053 |
BMI (kg/m2) | 46.80 ± 7.98 | 47.80 ± 8.50 | 49.47 ± 10.56 | 0.3733 | 0.0512 | 0.1715 |
WBC (x 103/uL) | 7.81 ± 2.54 | 8.08 ± 2.21 | 8.82 ± 8.81 | 0.3784 | 0.2855 | 0.3366 |
Platelets (x 103/uL) | 303.51 ± 69.73 | 291.01 ± 64.23 | 268.69 ± 66.97 | 0.1632 | 0.0005 | 0.0094 |
Insulin Resistance | 1.92 ± 2.83 | 2.40 ± 1.18 | 8.37 ± 11.00 | 0.4879 | 0.0413 | 0.0154 |
Glucose (mg/dL) | 94.16 ± 21.74 | 110.47 ± 36.20 | 120.22 ± 43.50 | 0.0002 | <.0001 | 0.0641 |
ALT (U/L) | 22.20 ± 9.74 | 31.58 ± 16.35 | 49.51 ± 37.25 | <.0001 | <.0001 | <.0001 |
AST (U/L) | 19.41 ± 5.57 | 23.49 ± 11.04 | 36.43 ± 29.69 | 0.0013 | <.0001 | <.0001 |
Triglycerides (mg/dL) | 125.84 ± 58.42 | 160.26 ± 87.31 | 182.10 ± 117.04 | 0.0018 | 0.0001 | 0.1152 |
LDL (mg/dL) | 100.96 ± 35.75 | 110.75 ± 35.40 | 111.71 ± 36.34 | 0.0620 | 0.0646 | 0.8555 |
Total cholesterol (mg/dL) | 175.84 ± 34.00 | 193.24 ± 39.40 | 190.10 ± 41.96 | 0.0011 | 0.0150 | 0.5683 |
HDL (mg/dL) | 50.40 ± 12.42 | 48.58 ± 13.63 | 42.68 ± 10.96 | 0.3461 | <.0001 | 0.0014 |
White: N (%) | 66 (70.2Â %) | 112 (78.3Â %) | 84 (80.8Â %) | 0.1579 | 0.0835 | 0.6389 |
Diabetes: N (%) | 17 (18.3Â %) | 44 (30.8Â %) | 46 (44.2Â %) | 0.0322 | <.0001 | 0.030 |
Hyperlipidemia: N (%) | 34 (37.4Â %) | 69 (50.0Â %) | 59 (59.6Â %) | 0.0599 | 0.0022 | 0.1438 |
Hypertension: N (%) | 40 (44.4Â %) | 81 (57.9Â %) | 64 (65.3Â %) | 0.0468 | 0.0041 | 0.2464 |
Sleep Apnea: N (%) | 53 (57.6Â %) | 100 (71.9Â %) | 81 (80.2Â %) | 0.0241 | 0.0007 | 0.1425 |